Anemia News and Research

RSS
Anemia is a decrease in normal number of red blood cells (RBCs) or less than the normal quantity of hemoglobin in the blood. However, it can include decreased oxygen-binding ability of each hemoglobin molecule due to deformity or lack in numerical development as in some other types of hemoglobin deficiency. The three main classes of anemia include excessive blood loss (acutely such as a hemorrhage or chronically through low-volume loss), excessive blood cell destruction (hemolysis) or deficient red blood cell production (ineffective hematopoiesis). Anemia is the most common disorder of the blood. There are several kinds of anemia, produced by a variety of underlying causes. Anemia can be classified in a variety of ways, based on the morphology of RBCs, underlying etiologic mechanisms, and discernible clinical spectra, to mention a few.
Malaria No More honors Hillary Rodham Clinton with Global Leadership Award

Malaria No More honors Hillary Rodham Clinton with Global Leadership Award

Imbruvica gets FDA approval for treatment of mantle cell lymphoma

Imbruvica gets FDA approval for treatment of mantle cell lymphoma

FibroGen presents China-based Phase 2 study data of roxadustat for treatment of CKD patients

FibroGen presents China-based Phase 2 study data of roxadustat for treatment of CKD patients

Results announced for Phase 3B/4 study of RAPAMUNE in kidney transplant patients

Results announced for Phase 3B/4 study of RAPAMUNE in kidney transplant patients

Generating an alternative to IVIG therapy: an interview with Professor Richard Pleass, LSTM

Generating an alternative to IVIG therapy: an interview with Professor Richard Pleass, LSTM

Multiple pregnancies: A major public health concern worldwide

Multiple pregnancies: A major public health concern worldwide

NIDDK director to receive Outstanding Achievement Award from NKF

NIDDK director to receive Outstanding Achievement Award from NKF

DaVita HealthCare announces results for third quarter 2013

DaVita HealthCare announces results for third quarter 2013

CHEO-led study confirms validity, reliability of quality of life measurement tool for thalassemia major

CHEO-led study confirms validity, reliability of quality of life measurement tool for thalassemia major

Current percutaneous techniques shed light on treatment of heart valve leakage

Current percutaneous techniques shed light on treatment of heart valve leakage

ARIAD temporarily suspends commercial distribution of Iclusig drug in US

ARIAD temporarily suspends commercial distribution of Iclusig drug in US

Honey may be detrimental for patients with type 2 diabetes

Honey may be detrimental for patients with type 2 diabetes

3Sbio acquires patents for DJ5 to delay hereditary renal disease in ADPKD patients

3Sbio acquires patents for DJ5 to delay hereditary renal disease in ADPKD patients

Rituximab drug may be safe, effective for immunoglobulin G4-related disease treatment

Rituximab drug may be safe, effective for immunoglobulin G4-related disease treatment

Lupus disparities: Young, black women have highest rate of developing lupus

Lupus disparities: Young, black women have highest rate of developing lupus

Kaiser Permanente researchers named co-recipients of Drug Therapy Research Literature Award

Kaiser Permanente researchers named co-recipients of Drug Therapy Research Literature Award

Findings shed light on the impact, treatment concerns related to uterine fibroids

Findings shed light on the impact, treatment concerns related to uterine fibroids

Case Western oral pain expert encourages people with persistent mouth pain to check for BMS

Case Western oral pain expert encourages people with persistent mouth pain to check for BMS

New PARP inhibitor shows early responses in patients with advanced BRCA-related cancers

New PARP inhibitor shows early responses in patients with advanced BRCA-related cancers

Research: Low levels of vitamin D appear to increase child's risk of anemia

Research: Low levels of vitamin D appear to increase child's risk of anemia

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.